Chiron Warns Of Flu Vaccine Shortfall
LOS ANGELES (Reuters) - Chiron Corp. on Monday said its U.S. flu vaccine deliveries, and its profit, will fall short of expectations yet again this year due to production problems that plagued its British manufacturing plant.